See more : Abivax SA American Depositary Shares (ABVX) Income Statement Analysis – Financial Results
Complete financial analysis of Actinogen Medical Limited (ACW.AX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Actinogen Medical Limited, a leading company in the Biotechnology industry within the Healthcare sector.
- Meritz Securities Co., Ltd. (008560.KS) Income Statement Analysis – Financial Results
- Elisa Oyj (ELMUF) Income Statement Analysis – Financial Results
- Tamino Minerals, Inc. (TINO) Income Statement Analysis – Financial Results
- Mastercard Incorporated (MA) Income Statement Analysis – Financial Results
- Nyxio Technologies Corporation (NYXO) Income Statement Analysis – Financial Results
Actinogen Medical Limited (ACW.AX)
About Actinogen Medical Limited
Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It is developing Xanamem, an inhibitor of the 11ß-HSD1 enzyme, which is in Phase 2 clinical trials that achieves target engagement in the central nervous system, Alzheimer's disease, depression with cognitive impairment, and anxiety, sleep, and behavioral problems in fragile X syndrome. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited was incorporated in 1999 and is based in Sydney, Australia.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 9.93M | 4.89M | 3.64M | 1.98M | 3.52M | 4.86M | 3.30M | 1.42M | 3.95M | 153.43K | 181.20K | 3.10K | 51.56K | 94.45K | 92.80K | 128.13K | 155.88K |
| Cost of Revenue | 0.00 | 405.61K | 400.67K | 386.70K | 412.93K | 353.50K | 356.04K | 360.62K | 365.33K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 9.93M | 4.48M | 3.24M | 1.60M | 3.10M | 4.51M | 2.94M | 1.05M | 3.59M | 153.43K | 181.20K | 3.10K | 51.56K | 94.45K | 92.80K | 128.13K | 155.88K |
| Gross Profit Ratio | 100.00% | 91.70% | 88.99% | 80.51% | 88.26% | 92.73% | 89.21% | 74.52% | 90.76% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Research & Development | 15.54M | 8.90M | 8.21M | 2.41M | 5.54M | 10.90M | 7.74M | 3.19M | 5.61M | 2.76M | 218.68K | 289.16K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.73M | 1.79M | 1.36M | 1.12M | 1.23M | 658.89K | 2.27M | 684.88K | 2.16M | 600.58K | 194.29K | 183.06K | 714.86K | 699.46K | 631.59K | 676.74K | 422.74K |
| Selling & Marketing | 5.50M | 4.77M | 3.20M | 1.99M | 1.73M | 776.05K | 528.42K | 294.95K | 539.76K | 1.86M | 171.62K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 7.24M | 6.57M | 4.56M | 3.11M | 2.96M | 3.22M | 1.46M | 1.05M | 1.60M | 2.60M | 365.91K | 183.06K | 714.86K | 699.46K | 631.59K | 676.74K | 422.74K |
| Other Expenses | 0.00 | 4.77M | 3.65M | 1.98M | 3.52M | 4.78M | 3.30M | 1.38M | 3.85M | 0.00 | 146.95K | 2.43K | 446.57K | 410.44K | 63.36K | 233.02K | 60.18K |
| Operating Expenses | 22.77M | 15.47M | 12.77M | 5.52M | 8.50M | 14.95M | 9.21M | 4.24M | 7.21M | 5.58M | 620.70K | 457.39K | 1.16M | 1.11M | 1.05M | 909.76K | 591.53K |
| Cost & Expenses | 22.77M | 15.87M | 13.17M | 5.90M | 8.91M | 14.95M | 9.56M | 4.60M | 7.58M | 5.58M | 620.70K | 457.39K | 1.16M | 1.11M | 1.05M | 909.76K | 591.53K |
| Interest Income | 291.02K | 366.65K | 41.07K | 27.09K | 94.06K | 196.56K | 38.72K | 37.54K | 104.17K | 4.95K | 722.00 | 2.64K | 12.88K | 35.63K | 44.39K | 102.54K | 142.24K |
| Interest Expense | 24.29K | 16.60K | 18.48K | 22.32K | 28.88K | 7.99K | 11.46K | 8.53K | 6.44K | 4.95K | 722.00 | 715.00 | 1.01K | 1.08K | 805.00 | 57.00 | 454.00 |
| Depreciation & Amortization | 416.83K | 405.61K | 400.67K | 386.70K | 412.93K | 353.50K | 356.04K | 360.62K | 365.33K | 221.43K | 13.60K | 16.93K | 19.37K | 19.55K | 17.37K | 13.83K | 1.62K |
| EBITDA | -12.92M | -15.22M | -12.72M | -5.35M | -8.20M | -9.25M | -5.91M | -2.82M | -3.26M | -5.20M | -426.63K | -438.01K | -1.77M | -1.01M | -900.10K | -1.06M | -434.04K |
| EBITDA Ratio | -130.10% | -316.44% | -350.89% | -278.08% | -241.70% | -190.30% | -278.92% | -299.31% | -182.52% | -3,536.53% | -222.61% | -13,936.01% | -2,089.94% | -1,054.38% | -948.37% | -599.26% | -278.45% |
| Operating Income | -12.84M | -15.87M | -13.17M | -5.90M | -8.91M | -9.61M | -9.56M | -4.60M | -7.58M | -5.42M | -416.98K | -457.39K | -1.11M | -1.05M | -1.01M | -884.17K | -577.44K |
| Operating Income Ratio | -129.28% | -324.74% | -361.90% | -297.57% | -253.44% | -197.57% | -289.70% | -324.79% | -191.76% | -3,535.55% | -230.12% | -14,745.10% | -2,152.49% | -1,112.80% | -1,083.19% | -690.08% | -370.45% |
| Total Other Income/Expenses | -10.14M | -5.06M | -4.00M | -2.22M | -3.66M | -633.84K | -3.48M | -1.63M | -4.12M | 146.98K | -36.84K | 2.46K | -676.65K | 26.06K | 87.73K | -194.52K | 141.78K |
| Income Before Tax | -22.98M | -15.64M | -13.14M | -5.75M | -8.65M | -9.89M | -9.39M | -4.45M | -7.38M | -5.43M | -440.22K | -454.94K | -1.79M | -1.03M | -917.48K | -1.08M | -435.66K |
| Income Before Tax Ratio | -231.34% | -319.98% | -360.91% | -290.03% | -245.87% | -203.33% | -284.44% | -314.38% | -186.75% | -3,539.75% | -242.94% | -14,665.86% | -3,464.79% | -1,085.22% | -988.65% | -841.90% | -279.49% |
| Income Tax Expense | -9.93M | -4.89M | -3.64M | -1.84M | -3.32M | 181.64K | -3.16M | -1.26M | -3.75M | -222.93K | 0.00 | -290.27K | -257.36K | -282.64K | -180.01K | -151.75K | 141.78K |
| Net Income | -13.04M | -10.75M | -9.50M | -3.92M | -5.33M | -9.89M | -6.23M | -3.19M | -3.63M | -5.43M | -440.22K | -164.66K | -1.53M | -742.38K | -737.47K | -926.94K | -435.66K |
| Net Income Ratio | -131.34% | -219.98% | -260.91% | -197.32% | -151.59% | -203.33% | -188.76% | -225.39% | -91.93% | -3,539.75% | -242.94% | -5,308.28% | -2,965.66% | -785.98% | -794.68% | -723.46% | -279.49% |
| EPS | -0.01 | -0.01 | -0.01 | 0.00 | 0.00 | -0.01 | -0.01 | 0.00 | -0.01 | -0.01 | 0.00 | 0.00 | -0.04 | -0.03 | -0.03 | -0.04 | -0.02 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | 0.00 | 0.00 | -0.01 | -0.01 | 0.00 | -0.01 | -0.01 | 0.00 | 0.00 | -0.04 | -0.03 | -0.03 | -0.04 | -0.02 |
| Weighted Avg Shares Out | 2.17B | 1.88B | 1.79B | 1.46B | 1.19B | 1.10B | 749.06M | 646.99M | 644.04M | 438.12M | 151.85M | 44.60M | 36.78M | 22.76M | 23.55M | 23.60M | 22.29M |
| Weighted Avg Shares Out (Dil) | 2.17B | 1.88B | 1.79B | 1.46B | 1.19B | 1.10B | 749.06M | 646.99M | 644.04M | 438.12M | 152.63M | 45.50M | 36.78M | 22.76M | 23.55M | 23.60M | 22.29M |
Source: https://incomestatements.info
Category: Stock Reports